Quarterly report pursuant to Section 13 or 15(d)

Summary of Warrant Activity (Details)

v3.21.2
Summary of Warrant Activity (Details)
 6 Months Ended
Jun. 30, 2021
USD ($)
$ / shares
shares
Common Stock Warrants [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Number of Warrants, Beginning Balance | shares
Weighted Average Exercise Price, Beginning Balance | $ / shares
Weighted Average Remaining Contractual Term (years), Beginning
Aggregate Intrinsic Value, Beginning | $
Number of Warrants, Assumed from Merger | shares 5,363,547
Weighted Average Exercise Price, Assumed from Merger | $ / shares $ 5.19
Weighted Average Remaining Contractual Term (years), Assumed from Merger 5 years 7 days
Number of Warrants, Granted | shares
Weighted Average Exercise Price, Granted | $ / shares
Weighted Average Remaining Contractual Term (years), Granted
Aggregate Intrinsic Value, Granted | $
Number of Warrants, Exercised | shares
Weighted Average Exercise Price, Exercised | $ / shares
Weighted Average Remaining Contractual Term (years), Exercised
Aggregate Intrinsic Value, Exercised | $
Number of Warrants, Forfeited | shares
Weighted Average Exercise Price, Forfeited | $ / shares
Weighted Average Remaining Contractual Term (years), Forfeited
Aggregate Intrinsic Value, Forfeited | $
Number of Warrants, Cancelled/Expired | shares
Weighted Average Exercise Price, Cancelled/Expired | $ / shares
Weighted Average Remaining Contractual Term (years), Canceled/Expired
Aggregate Intrinsic Value, Cancelled/Expired | $
Number of Warrants, Ending Balance | shares 5,363,547
Weighted Average Exercise Price, Ending Balance | $ / shares $ 5.19
Weighted Average Remaining Contractual Term (years), Ending 4 years 10 months 6 days
Aggregate Intrinsic Value, Ending | $ $ 11,366,055
Number of Warrants, Exercisable | shares 5,363,547
Weighted Average Exercise Price, Exercisable | $ / shares $ 5.19
Weighted Average Remaining Contractual Term (years), Exercisable 4 years 10 months 6 days
Aggregate Intrinsic Value, Exercisable | $ $ 11,366,055
Pre-funded Common Stock Warrants [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Number of Warrants, Beginning Balance | shares
Weighted Average Exercise Price, Beginning Balance | $ / shares
Weighted Average Remaining Contractual Term (years), Beginning
Aggregate Intrinsic Value, Beginning | $
Number of Warrants, Assumed from Merger | shares 986,486
Weighted Average Exercise Price, Assumed from Merger | $ / shares $ 0.002
Number of Warrants, Granted | shares
Weighted Average Exercise Price, Granted | $ / shares
Weighted Average Remaining Contractual Term (years), Granted
Aggregate Intrinsic Value, Granted | $
Number of Warrants, Exercised | shares 466,216
Weighted Average Exercise Price, Exercised | $ / shares $ 0.002
Weighted Average Remaining Contractual Term (years), Exercised
Aggregate Intrinsic Value, Exercised | $
Number of Warrants, Forfeited | shares
Weighted Average Exercise Price, Forfeited | $ / shares
Weighted Average Remaining Contractual Term (years), Forfeited
Aggregate Intrinsic Value, Forfeited | $
Number of Warrants, Cancelled/Expired | shares
Weighted Average Exercise Price, Cancelled/Expired | $ / shares
Weighted Average Remaining Contractual Term (years), Canceled/Expired
Aggregate Intrinsic Value, Cancelled/Expired | $
Number of Warrants, Ending Balance | shares 520,270
Weighted Average Exercise Price, Ending Balance | $ / shares $ 0.002
Weighted Average Remaining Contractual Term (years), Ending
Aggregate Intrinsic Value, Ending | $ $ 3,276,600
Number of Warrants, Exercisable | shares 520,270
Weighted Average Exercise Price, Exercisable | $ / shares $ 0.002
Weighted Average Remaining Contractual Term (years), Exercisable
Aggregate Intrinsic Value, Exercisable | $ $ 3,276,660
Series C Convertible Preferred Stock [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Number of Warrants, Beginning Balance | shares
Weighted Average Exercise Price, Beginning Balance | $ / shares
Weighted Average Remaining Contractual Term (years), Beginning
Aggregate Intrinsic Value, Beginning | $
Number of Warrants, Assumed from Merger | shares 27,500
Weighted Average Exercise Price, Assumed from Merger | $ / shares $ 8.00
Weighted Average Remaining Contractual Term (years), Assumed from Merger 3 years 7 months 24 days
Number of Warrants, Granted | shares
Weighted Average Exercise Price, Granted | $ / shares
Weighted Average Remaining Contractual Term (years), Granted
Aggregate Intrinsic Value, Granted | $
Number of Warrants, Exercised | shares
Weighted Average Exercise Price, Exercised | $ / shares
Weighted Average Remaining Contractual Term (years), Exercised
Aggregate Intrinsic Value, Exercised | $
Number of Warrants, Forfeited | shares
Weighted Average Exercise Price, Forfeited | $ / shares
Weighted Average Remaining Contractual Term (years), Forfeited
Aggregate Intrinsic Value, Forfeited | $
Number of Warrants, Cancelled/Expired | shares
Weighted Average Exercise Price, Cancelled/Expired | $ / shares
Weighted Average Remaining Contractual Term (years), Canceled/Expired
Aggregate Intrinsic Value, Cancelled/Expired | $
Number of Warrants, Ending Balance | shares 27,500
Weighted Average Exercise Price, Ending Balance | $ / shares $ 8.00
Weighted Average Remaining Contractual Term (years), Ending 3 years 5 months 12 days
Aggregate Intrinsic Value, Ending | $
Number of Warrants, Exercisable | shares 27,500
Weighted Average Exercise Price, Exercisable | $ / shares $ 8.00
Weighted Average Remaining Contractual Term (years), Exercisable 3 years 5 months 12 days
Aggregate Intrinsic Value, Exercisable | $